An observational study to characterize the patient population diagnosed with sarcopenia.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2018
At a glance
- Drugs Sarconeos (Primary)
- Indications Muscular atrophy
- Focus Adverse reactions
- Acronyms SARA-OBS
- 01 Mar 2018 According to a Biophytis media release, data from this trial will be presented at the 8th International Conference on Frailty & Sarcopenia Research (2018).
- 04 Dec 2017 According to a Biophytis media release, University Hospital of Liege, trial site has been opened.
- 30 Oct 2017 According to a Biophytits media release, recruitment has been initiated at the Jean Mayer Human Nutrition Research Center on Aging (Tufts University School of Medicine) in Boston and at The Institute on Aging (University of Florida) in Gainesville.